U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911554) titled 'A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites' on March 25.
Brief Summary: This study was a Phase III multicenter, blinded, and positive active-controlled clinical study to evaluate the efficacy, safety, and immunogenicity of recombinant human albumin(rHA) injection for the treatment of hypoalbuminemia in cirrhotic patients with ascites.
Study Start Date: June 16, 2023
Study Type: INTERVENTIONAL
Condition:
Hepatic Ascites
Intervention:
BIOLOGICAL: Recombinant Human Albumin Injection
Recombinant Human Albumin injection, strength: 10 g/vial (20%, 50 mL); storage condi...